Lifecore Biomedical, Inc. (LFCR) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LFCR Revenue Growth
LFCR Revenue Analysis (2014–2025)
As of May 8, 2026, Lifecore Biomedical, Inc. (LFCR) generated trailing twelve-month (TTM) revenue of $135.2 million, reflecting significant decline in growth of -34.0% year-over-year. The most recent quarter (Q3 2026) recorded $23.2 million in revenue, down 47.8% sequentially.
Looking at the longer-term picture, LFCR's 5-year compound annual growth rate (CAGR) stands at -4.2%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $557.6 million in 2019.
When compared to Healthcare sector peers including PCRX (+4.6% YoY), HALO (+37.6% YoY), and ATRC (+15.0% YoY), LFCR has underperformed the peer group in terms of revenue growth. Compare LFCR vs PCRX →
LFCR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LFCRCurrent | $135M | -34.0% | -4.2% | -13.4% | |
 PCRX | $726M | +4.6% | +11.1% | 4.6% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
LFCR Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $128.9M | +0.5% | $40.3M | 31.3% | $-17,245,000 | -13.4% |
| 2024 | $128.3M | +24.2% | $41.9M | 32.6% | $-8,844,000 | -6.9% |
| 2023 | $103.3M | -7.2% | $28.0M | 27.1% | $-21,796,000 | -21.1% |
| 2022 | $111.3M | +10.3% | $39.1M | 35.1% | $-11,791,000 | -10.6% |
| 2021 | $100.9M | -37.0% | $38.9M | 38.6% | $-8,823,000 | -8.7% |
| 2020 | $160.1M | -71.3% | $39.4M | 24.6% | $-25,876,000 | -16.2% |
| 2019 | $557.6M | +6.4% | $81.0M | 14.5% | $-8,010,000 | -1.4% |
| 2018 | $524.2M | -1.5% | $78.3M | 14.9% | $11.8M | 2.3% |
| 2017 | $532.3M | -1.6% | $83.2M | 15.6% | $15.5M | 2.9% |
| 2016 | $541.1M | +0.3% | $71.0M | 13.1% | $-19,786,000 | -3.7% |
See LFCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFCR — Frequently Asked Questions
Quick answers to the most common questions about buying LFCR stock.
Is LFCR's revenue growth accelerating or slowing?
LFCR revenue declined -34.0% year-over-year, contrasting with the 5-year CAGR of -4.2%. TTM revenue fell to $135M. This reverses the prior growth trend.
What is LFCR's long-term revenue growth rate?
Lifecore Biomedical, Inc.'s 5-year revenue CAGR of -4.2% reflects the variable expansion pattern. Current YoY growth of -34.0% is below this long-term average.
How is LFCR's revenue distributed by segment?
LFCR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.